MedX Health Signs Exclusive Distribution Agreement to Launch SIAscopy on DermSecure in Mexico

MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it has signed an Exclusive Distribution Agreement with EMC LABS, S.A.P.I. DE C.V., operating as MedX Mexico (“MedX Mexico”), which plans to launch an aggressive ease-of-access skin scanning/assessment program throughout Mexico, using MedX’s SIAscopy on DermSecure™ Telemedicine platform. The exclusivity was granted to MedX Mexico based on its strong connections within the Mexican marketplace as well as its upfront commitment to cover the application for regulatory approval in Mexico and all marketing costs, and the large-scale distribution network it has secured. The agreement also has a robust performance clause that reflects the strong commitment by MedX Mexico and the opportunity in the Mexican market.

“There is a significant opportunity for MedX’s rapid skin assessment technology in Mexico, as skin cancer is a very common type of cancer in Mexico,” stated Carlos Vizcaino, MedX Mexico’s, President and CEO. “A recent study shows that Mexican melanoma patients experience a lower survival rate than the current worldwide average. This fact is based on two factors, namely late stage diagnosis due to the lack of early screening and the ill-informed belief that our community is not as susceptible as others to skin cancer. The high prevalence of advanced cases reinforces the importance of local strategies to diagnose melanoma in the early stages, to treat it definitively and to be able to reach many underserved communities. MedX’s SIAscopy on DermSecure™ Telemedicine platform and advanced SIAscopy imaging technology is a perfect solution to assist dermatologists and physicians in the diagnosis process for early detection of melanoma,” further noted Mr. Vizcaino.

“MedX Mexico has experience in marketing medical devices and health solutions in the Mexican market, as well as a strong connections with hospitals, major pharmacies and medical clinics which will be a great benefit as it enters into this large market, and we are delighted to be partnering with them,” noted Scott Spearn, President & CEO of MedX. – Business Wire